Panayiotis A. Koutentis
University of Cyprus
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Panayiotis A. Koutentis.
European Journal of Medicinal Chemistry | 2011
Antreas Afantitis; Georgia Melagraki; Panayiotis A. Koutentis; Haralambos Sarimveis; George Kollias
In this work we have developed an in silico model to predict the inhibition of β-amyloid aggregation by small organic molecules. In particular we have explored the inhibitory activity of a series of 62 N-phenylanthranilic acids using Kohonen maps and Counterpropagation Artificial Neural Networks. The effects of various structural modifications on biological activity are investigated and novel structures are designed using the developed in silico model. More specifically a search for optimized pharmacophore patterns by insertions, substitutions, and ring fusions of pharmacophoric substituents of the main building block scaffolds is described. The detection of the domain of applicability defines compounds whose estimations can be accepted with confidence.
Molecular Diversity | 2006
Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
SummaryA quantitative–structure activity relationship was obtained by applying Multiple Linear Regression Analysis to a series of 80 1-[2-hydroxyethoxy-methyl]-6-(phenylthio) thymine (HEPT) derivatives with significant anti-HIV activity. For the selection of the best among 37 different descriptors, the Elimination Selection Stepwise Regression Method (ES-SWR) was utilized. The resulting QSAR model (R2CV = 0.8160; SPRESS = 0.5680) proved to be very accurate both in training and predictive stages.
Journal of Organic Chemistry | 2011
Christos P. Constantinides; Panayiotis A. Koutentis; Harry Krassos; Jeremy M. Rawson; Anastasios J. Tasiopoulos
1,3-Diphenyl-7-trifluoromethyl-1,4-dihydro-1,2,4-benzotriazin-4-yl (4), prepared in high yield via the catalytic oxidation of the corresponding amidrazone 5 by using Pd/C (1.6 mol %) and 1,8-diazabicyclo[5.4.0]undec-7-ene (0.1 equiv) in air, is stable in dichloromethane solutions in the presence of MnO(2) and KMnO(4). Furthermore, radical 4 is thermally stable well past its melting point (160-161 °C) with a decomposition onset temperature of 288 °C. X-ray studies show that radical 4 packs in equidistant slipped π-stacks along the a axis. Cyclic voltammetry shows two fully reversible waves, corresponding to the -1/0, 0/+1 processes. EPR studies indicate that the spin density is mainly delocalized on the triazinyl fragment of the heterocycle. Magnetic susceptibility measurements in the 5-300 K region showed that the radical obeys Curie-Weiss behavior down to 10 K (C = 0.376 emu·K·mol(-1) and θ = +1.41 K) consistent with weak ferromagnetic interactions between S = 1/2 radicals. Subsequent fitting of the magnetic data to a 1D ferromagnetic chain model provided an excellent fit (g = 2.00, J/k = +1.49 K) down to 10 K but failed to reproduce the subsequent decrease in χT at lower temperatures, which has been ascribed to the onset of weaker antiferromagnetic interactions between ferromagnetic chains.
Molecular Diversity | 2010
Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; Olga Igglessi-Markopoulou; George Kollias
A novel QSAR workflow is constructed that combines MLR with LS-SVM classification techniques for the identification of quinazolinone analogs as “active” or “non-active” CXCR3 antagonists. The accuracy of the LS-SVM classification technique for the training set and test was 100% and 90%, respectively. For the “active” analogs a validated MLR QSAR model estimates accurately their I-IP10 IC50 inhibition values. The accuracy of the QSAR model (R2 = 0.80) is illustrated using various evaluation techniques, such as leave-one-out procedure
Journal of Computer-aided Molecular Design | 2006
Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A. Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
Molecular Diversity | 2009
Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Panayiotis A. Koutentis; George Kollias; Olga Igglessi-Markopoulou
{(R^{2}_{\rm LOO} =0.67)}
Toxicology and Applied Pharmacology | 2012
Francesca Oppedisano; Marco Catto; Panayiotis A. Koutentis; Orazio Nicolotti; Lorena Pochini; Maria Koyioni; Antonellina Introcaso; Sophia S. Michaelidou; Angelo Carotti; Cesare Indiveri
Chemical Biology & Drug Design | 2010
Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Olga Igglessi-Markopoulou; Panayiotis A. Koutentis; George Kollias
and validation through an external test set
Chemistry: A European Journal | 2012
Christos P. Constantinides; Panayiotis A. Koutentis; Jeremy M. Rawson
Organic and Biomolecular Chemistry | 2011
Christos P. Constantinides; Panayiotis A. Koutentis; Georgia Loizou
{(R^{2}_{\rm pred} =0.78)}